These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24332891)

  • 1. Evaluating negative-symptom-like behavioural changes in developmental models of schizophrenia.
    Moser P
    Eur Neuropsychopharmacol; 2014 May; 24(5):774-87. PubMed ID: 24332891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
    Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
    Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified mice related to schizophrenia and other psychoses: seeking phenotypic insights into the pathobiology and treatment of negative symptoms.
    O'Tuathaigh CM; Desbonnet L; Waddington JL
    Eur Neuropsychopharmacol; 2014 May; 24(5):800-21. PubMed ID: 24290531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral phenotypes for negative symptoms in animal models of schizophrenia.
    Miyamoto Y; Nitta A
    J Pharmacol Sci; 2014; 126(4):310-20. PubMed ID: 25409784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.
    Millan MJ; Fone K; Steckler T; Horan WP
    Eur Neuropsychopharmacol; 2014 May; 24(5):645-92. PubMed ID: 24820238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
    Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
    Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.
    Barnes SA; Der-Avakian A; Markou A
    Eur Neuropsychopharmacol; 2014 May; 24(5):744-58. PubMed ID: 24183826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MAM-E17 schizophrenia rat model].
    Kállai V; Tóth A; Gálosi R; Szabó I; Petykó Z; Karádi Z; Kállai J; Lénárd L
    Psychiatr Hung; 2015; 30(1):4-17. PubMed ID: 25867884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal deprivation in the middle of a stress hyporesponsive period decreases hippocampal calcineurin expression and causes abnormal social and cognitive behaviours in adult male Wistar rats: relevance to negative symptoms of schizophrenia.
    Takase K; Yamamoto Y; Yagami T
    Behav Brain Res; 2012 Jun; 232(1):306-15. PubMed ID: 22543011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders.
    Foussias G; Agid O; Fervaha G; Remington G
    Eur Neuropsychopharmacol; 2014 May; 24(5):693-709. PubMed ID: 24275699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of personal narratives as a mediator of the impact of deficits in social cognition and social withdrawal on negative symptoms in schizophrenia.
    Lysaker PH; Erikson M; Macapagal KR; Tunze C; Gilmore E; Ringer JM
    J Nerv Ment Dis; 2012 Apr; 200(4):290-5. PubMed ID: 22456581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.
    Wilson CA; Koenig JI
    Eur Neuropsychopharmacol; 2014 May; 24(5):759-73. PubMed ID: 24342774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurodevelopmental model of schizophrenia: update 2005.
    Rapoport JL; Addington AM; Frangou S; Psych MR
    Mol Psychiatry; 2005 May; 10(5):434-49. PubMed ID: 15700048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Negative Symptoms in Schizophrenia - an Overview].
    Klaus F; Kaiser S; Kirschner M
    Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral animal models of antipsychotic drug actions.
    Peleg-Raibstein D; Feldon J; Meyer U
    Handb Exp Pharmacol; 2012; (212):361-406. PubMed ID: 23129339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural basis of psychosis-related behaviour in the infection model of schizophrenia.
    Meyer U; Feldon J
    Behav Brain Res; 2009 Dec; 204(2):322-34. PubMed ID: 19154759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.